nach oben

Erschienen in:

01.09.2011 | Original paper

Genetic variants in the folate pathway and risk of childhood acute lymphoblastic leukemia

verfasst von: Catherine Metayer, Ghislaine Scélo, Anand P. Chokkalingam, Lisa F. Barcellos, Melinda C. Aldrich, Jeffrey S. Chang, Neela Guha, Kevin Y. Urayama, Helen M. Hansen, Gladys Block, Vincent Kiley, John K. Wiencke, Joseph L. Wiemels, Patricia A. Buffler

Erschienen in: Cancer Causes & Control | Ausgabe 9/2011

Einloggen, um Zugang zu erhalten

Abstract

Objective

Folate is involved in the one-carbon metabolism that plays an essential role in the synthesis, repair, and methylation of DNA. We examined whether child’s germline genetic variation in the folate pathway is associated with childhood acute lymphoblastic leukemia (ALL), and whether periconception maternal folate and alcohol intake modify the risk.

Methods

Seventy-six single nucleotide polymorphisms (SNPs), including 66 haplotype-tagging SNPs in 10 genes (CBS, DHFR, FOLH1, MTHFD1, MTHFR, MTR, MTRR, SHMT1, SLC19A1, and TYMS), were genotyped in 377 ALL cases and 448 controls. Log-additive associations between genotypes and ALL risk were adjusted for age, sex, Hispanic ethnicity (when appropriate), and maternal race.

Results

Single and haplotype SNPs analyses showed statistically significant associations between SNPs located in (or adjacent to) CBS, MTRR, TYMS/ENOFS, and childhood ALL. Many regions of CBS were associated with childhood ALL in Hispanics and non-Hispanics (p < 0.01). Levels of maternal folate intake modified associations with SNPs in CBS, MTRR, and TYMS.

Conclusion

Our data suggest the importance of genetic variability in the folate pathway and childhood ALL risk.

Ferlay J, Bray F, Pisani P, Parkin DM (2004) Globocan 2002—Cancer incidence, mortality and prevalence worldwide (IARC CancerBase No. 5, version 2.0)

Parkin DM, Whelan SL, Ferlay J, Storm H (2005) Cancer in five continents, vol I to VIII (IARC CancerBase No. 7)

Greaves M (2006) Infection, immune responses and the aetiology of childhood leukaemia. Nat Rev Cancer 6:193–203PubMedCrossRef

Friso S, Choi SW (2005) Gene-nutrient interactions in one-carbon metabolism. Curr Drug Metab 6:37–46PubMedCrossRef

Duthie SJ (1999) Folic acid deficiency and cancer: mechanisms of DNA instability. Br Med Bull 55:578–592PubMedCrossRef

Thompson JR, Gerald PF, Willoughby ML, Armstrong BK (2001) Maternal folate supplementation in pregnancy and protection against acute lymphoblastic leukaemia in childhood: a case-control study. Lancet 358:1935–1940PubMedCrossRef

Wiemels JL, Smith RN, Taylor GM, Eden OB, Alexander FE, Greaves MF (2001) Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and risk of molecularly defined subtypes of childhood acute leukemia. Proc Natl Acad Sci USA 98:4004–4009PubMedCrossRef

Franco RF, Simoes BP, Tone LG, Gabellini SM, Zago MA, Falcao RP (2001) The methylenetetrahydrofolate reductase C677T gene polymorphism decreases the risk of childhood acute lymphocytic leukaemia. Br J Haematol 115:616–618PubMedCrossRef

Krajinovic M, Lamothe S, Labuda D et al (2004) Role of MTHFR genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia. Blood 103:252–257PubMedCrossRef

10.

Gast A, Bermejo JL, Flohr T et al (2007) Folate metabolic gene polymorphisms and childhood acute lymphoblastic leukemia: a case-control study. Leukemia 21:320–325PubMedCrossRef

11.

Bailey LB (2003) Folate, methyl-related nutrients, alcohol, and the MTHFR 677C→T polymorphism affect cancer risk: intake recommendations. J Nutr 133:3748S–3753SPubMed

12.

Thirumaran RK, Gast A, Flohr T et al (2005) MTHFR genetic polymorphisms and susceptibility to childhood acute lymphoblastic leukemia [letter]. Blood 106:2590–2591PubMedCrossRef

13.

Milne E, de Klerk NH, van Bockxmeer F et al (2006) Is there a folate-related gene-environment interaction in the etiology of childhood acute lymphoblastic leukemia? Int J Cancer 119:229–232PubMedCrossRef

14.

Zintzaras E, Koufakis T, Ziakas PD, Rodopoulou P, Giannouli S, Voulgarelis M (2006) A meta-analysis of genotypes and haplotypes of methylenetetrahydrofolate reductase gene polymorphisms in acute lymphoblastic leukemia. Eur J Epidemiol 21:501–510PubMedCrossRef

15.

Pereira TV, Rudnicki M, Pereira AC, Pombo-de-Oliveira MS, Franco RF (2006) 5, 10-Methylenetetrahydrofolate reductase polymorphisms and acute lymphoblastic leukemia risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 15:1956–1963PubMedCrossRef

16.

Alcasabas P, Ravindranath Y, Goyette G et al (2008) 5, 10-methylenetetrahydrofolate reductase (MTHFR) polymorphisms and the risk of acute lymphoblastic leukemia (ALL) in Filipino children. Pediatr Blood Cancer 51:178–182PubMedCrossRef

17.

Amorim MR, Zanrosso CW, Magalhaes IQ et al (2008) MTHFR 677C→T and 1298A→C polymorphisms in children with Down syndrome and acute myeloid leukemia in Brazil. Pediatr Hematol Oncol 25:744–750PubMedCrossRef

18.

Schnakenberg E, Mehles A, Cario G et al (2005) Polymorphisms of methylenetetrahydrofolate reductase (MTHFR) and susceptibility to pediatric acute lymphoblastic leukemia in a German study population. BMC Med Genet 6:23PubMedCrossRef

19.

Balta G, Yuksek N, Ozyurek E et al (2003) Characterization of MTHFR, GSTM1, GSTT1, GSTP1, and CYP1A1 genotypes in childhood acute leukemia. Am J Hematol 73:154–160PubMedCrossRef

20.

de Jonge R, Tissing WJ, Hooijberg JH et al (2009) Polymorphisms in folate-related genes and risk of pediatric acute lymphoblastic leukemia. Blood 113:2284–2289PubMedCrossRef

21.

Petra BG, Janez J, Vita D (2007) Gene-gene interactions in the folate metabolic pathway influence the risk for acute lymphoblastic leukemia in children. Leuk Lymphoma 48:786–792PubMedCrossRef

22.

Kamel AM, Moussa HS, Ebid GT, Bu RR, Bhatia KG (2007) Synergistic effect of methyltetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphism as risk modifiers of pediatric acute lymphoblastic leukemia. J Egypt Natl Canc Inst 19:96–105PubMed

23.

Lightfoot TJ, Johnston WT, Painter D et al (2010) Genetic variation in the folate metabolic pathway and risk of childhood leukemia. Blood 115:3923–3929PubMedCrossRef

24.

Yeoh AE, Lu Y, Chan JY et al (2010) Genetic susceptibility to childhood acute lymphoblastic leukemia shows protection in Malay boys: results from the Malaysia-Singapore ALL Study Group. Leuk Res 34:276–283PubMedCrossRef

25.

Gra OA, Glotov AS, Kozhekbaeva Z, Makarova OV, Nasedkina TV (2008) [Genetic polymorphism in GST, NAT2, and MTRR and susceptibility to childhood acute leukemia]. Mol Biol (Mosk) 42: 214–225 (Russian)

26.

Koppen IJ, Hermans FJ, Kaspers GJ (2010) Folate related gene polymorphisms and susceptibility to develop childhood acute lymphoblastic leukaemia. Br J Haematol 148:3–14PubMedCrossRef

27.

Mason JB, Choi SW (2005) Effects of alcohol on folate metabolism: implications for carcinogenesis. Alcohol 35:235–241PubMedCrossRef

28.

Ma X, Buffler PA, Layefsky M, Does MB, Reynolds P (2004) Control selection strategies in case-control studies of childhood diseases. Am J Epidemiol 159:915–921PubMedCrossRef

29.

Kwan ML, Block G, Selvin S, Month S, Buffler PA (2004) Food consumption by children and the risk of childhood acute leukemia. Am J Epidemiol 160:1098–1107PubMedCrossRef

30.

Bartley K, Metayer C, Selvin S, Ducore J, Buffler P (2010) Diagnostic X-rays and risk of childhood leukaemia. Int J Epidemiol 39:1628–1637PubMedCrossRef

31.

Hansen HM, Wiemels JL, Wrensch M, Wiencke JK (2007) DNA quantification of whole genome amplified samples for genotyping on a multiplexed bead array platform. Cancer Epidemiol Biomarkers Prev 16:1686–1690PubMedCrossRef

32.

Paynter RA, Skibola DR, Skibola CF, Buffler PA, Wiemels JL, Smith MT (2006) Accuracy of multiplexed Illumina platform-based single-nucleotide polymorphism genotyping compared between genomic and whole genome amplified DNA collected from multiple sources. Cancer Epidemiol Biomarkers Prev 15:2533–2536PubMedCrossRef

33.

Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263–265PubMedCrossRef

34.

The International HapMap Project (2003) Nature 426: 789–796

35.

Packer BR, Yeager M, Burdett L, Koppen IJ, Hermans FJ, Kaspers GJ (2006) SNP500Cancer: a public resource for sequence validation, assay development, and frequency analysis for genetic variation in candidate genes. Nucleic Acids Res 34:D617–D621PubMedCrossRef

36.

Gabriel SB, Schaffner SF, Nguyen H et al (2002) The structure of haplotype blocks in the human genome. Science 296:2225–2229PubMedCrossRef

37.

Chakraborty R, Weiss KM (1986) Frequencies of complex diseases in hybrid populations. Am J Phys Anthropol 70:489–503PubMedCrossRef

38.

Hanis CL, Chakraborty R, Ferrell RE, Schull WJ (1986) Individual admixture estimates: disease associations and individual risk of diabetes and gallbladder disease among Mexican-Americans in Starr County, Texas. Am J Phys Anthropol 70:433–441PubMedCrossRef

39.

Jensen CD, Block G, Buffler P, Ma X, Selvin S, Month S (2004) Maternal dietary risk factors in childhood acute lymphoblastic leukemia (United States). Cancer Causes Control 15:559–570PubMedCrossRef

40.

Yu Z, Schaid DJ (2007) Sequential haplotype scan methods for association analysis. Genet Epidemiol 31:553–564PubMedCrossRef

41.

Zaykin DV, Westfall PH, Young SS, Karnoub MA, Wagner MJ, Ehm MG (2002) Testing association of statistically inferred haplotypes with discrete and continuous traits in samples of unrelated individuals. Hum Hered 53:79–91PubMedCrossRef

42.

Mathias RA, Gao P, Goldstein JL et al (2006) A graphical assessment of p-values from sliding window haplotype tests of association to identify asthma susceptibility loci on chromosome 11q. BMC Genet 7:38PubMedCrossRef

43.

Pereira AC, Schettert IT, Morandini Filho AA, Guerra-Shinohara EM, Krieger JE (2004) Methylenetetrahydrofolate reductase (MTHFR) c677t gene variant modulates the homocysteine folate correlation in a mild folate-deficient population. Clin Chim Acta 340:99–105PubMedCrossRef

44.

McDowell MA, Lacher DA, Pfeiffer CM, et al. (2008) Blood folate levels: the latest NHANES results. NCHS Data Brief, 1–8

45.

Semmler A, Simon M, Moskau S, Linnebank M (2008) Polymorphisms of methionine metabolism and susceptibility to meningioma formation: laboratory investigation. J Neurosurg 108:999–1004PubMedCrossRef

46.

Le Marchand L, Donlon T, Hankin JH, Kolonel LN, Wilkens LR, Seifried A (2002) B-vitamin intake, metabolic genes, and colorectal cancer risk (United States). Cancer Causes Control 13:239–248PubMedCrossRef

47.

Ott N, Geddert H, Sarbia M (2008) Polymorphisms in methionine synthase (A2756G) and cystathionine beta-synthase (844ins68) and susceptibility to carcinomas of the upper gastrointestinal tract. J Cancer Res Clin Oncol 134:405–410PubMedCrossRef

48.

Shen M, Rothman N, Berndt SI et al (2005) Polymorphisms in folate metabolic genes and lung cancer risk in Xuan Wei, China. Lung Cancer 49:299–309PubMedCrossRef

49.

Chadefaux B, Rethore MO, Raoul O et al (1985) Cystathionine beta synthase: gene dosage effect in trisomy 21. Biochem Biophys Res Commun 128:40–44PubMedCrossRef

50.

Kim HN, Kim YK, Lee IK et al (2009) Association between polymorphisms of folate-metabolizing enzymes and hematological malignancies. Leuk Res 33:82–87PubMedCrossRef

51.

Murtaugh MA, Curtin K, Sweeney C et al (2007) Dietary intake of folate and co-factors in folate metabolism, MTHFR polymorphisms, and reduced rectal cancer. Cancer Causes Control 18:153–163PubMedCrossRef

52.

Zhang FF, Terry MB, Hou L et al (2007) Genetic polymorphisms in folate metabolism and the risk of stomach cancer. Cancer Epidemiol Biomarkers Prev 16:115–121PubMedCrossRef

53.

Arasaradnam RP, Commane DM, Bradburn D, Mathers JC (2008) A review of dietary factors and its influence on DNA methylation in colorectal carcinogenesis. Epigenetics 3:193–198PubMedCrossRef

54.

Hung RJ, Hashibe M, McKay J et al (2007) Folate-related genes and the risk of tobacco-related cancers in Central Europe. Carcinogenesis 28:1334–1340PubMedCrossRef

55.

Liu N, Zhang K, Zhao H (2008) Haplotype-association analysis. Adv Genet 60:335–405PubMedCrossRef

56.

Kwan ML, Jensen CD, Block G, Hudes ML, Chu LW, Buffler PA (2009) Maternal diet and risk of childhood acute lymphoblastic leukemia. Public Health Rep 124:503–514PubMed

57.

Caudill MA, Le T, Moonie SA, Esfahani ST, Cogger EA (2001) Folate status in women of childbearing age residing in Southern California after folic acid fortification. J Am Coll Nutr 20:129–134PubMed

Titel: Genetic variants in the folate pathway and risk of childhood acute lymphoblastic leukemia
verfasst von: Catherine Metayer
Ghislaine Scélo
Anand P. Chokkalingam
Lisa F. Barcellos
Melinda C. Aldrich
Jeffrey S. Chang
Neela Guha
Kevin Y. Urayama
Helen M. Hansen
Gladys Block
Vincent Kiley
John K. Wiencke
Joseph L. Wiemels
Patricia A. Buffler
Publikationsdatum: 01.09.2011
Verlag: Springer Netherlands
Erschienen in: Cancer Causes & Control / Ausgabe 9/2011
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI: https://doi.org/10.1007/s10552-011-9795-7

Neu im Fachgebiet Onkologie

25.04.2024 | Nierenkarzinom | Nachrichten

Springer Medizin

Genetic variants in the folate pathway and risk of childhood acute lymphoblastic leukemia

Abstract

Objective

Methods

Results

Conclusion

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Abstract

Objective

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 9/2011

Use of glucosamine and chondroitin and lung cancer risk in the VITamins And Lifestyle (VITAL) cohort

Medical history and the risk of biliary tract cancers in Shanghai, China: implications for a role of inflammation

Lifetime physical activity and the incidence of proliferative benign breast disease

Social inequalities or inequities in cancer incidence? Repeated census-cancer cohort studies, New Zealand 1981–1986 to 2001–2004

An examination of male and female odds ratios by BMI, cigarette smoking, and alcohol consumption for cancers of the oral cavity, pharynx, and larynx in pooled data from 15 case–control studies

Alternative approaches to assessing intervention effectiveness in randomized trials: application in a colorectal cancer screening study

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie